Nuclear factor erythroid-2 related factor 2 (Nrf2) is involved in mitigating various oxidative stress- and
inflammation-induced diseases, including
acute lung injury/
acute respiratory distress syndrome (ALI/ARDS).
Isorhapontigenin (ISO), from the Chinese herb Gnetum cleistostachyum, exhibits
antioxidant and anti-inflammatory properties. In this study, we explored the protective effects of ISO in ALI and its underlying molecular mechanisms. ISO significantly mitigated ALI by reducing the
lung wet/dry weight ratio,
protein concentration in the bronchoalveolar lavage fluid (BALF), and the levels of
myeloperoxidase and
malondialdehyde. ISO also improved the
superoxide dismutase and
glutathione activity in vivo. Moreover, ISO effectively ameliorated the changes in IL-1β,
IL-6, and TNF-α concentrations in BALF, prevented IκB degradation, and inhibited the phosphorylation of NF-κB p65 subunit in lung tissues; furthermore, it enhanced the nuclear translocation of Nrf2 and inhibited IL-1β,
IL-6, TNF-α, iNOS, COX-2, and ROS production in
lipopolysaccharide-treated RAW264.7 cells. The protective effects of ISO in ALI were significantly reversed in ML385-treated RAW264.7 cells and the mouse model, indicating its role in Nrf2-activation. In conclusion, ISO effectively ameliorated
lipopolysaccharide-induced ALI by reducing
inflammation and oxidative stress, primarily through activation of Nrf2 signaling.